⌘K

Home/Filings/4/0001214659-18-003243

4//SEC Filing

Brister Mark 4

Accession 0001214659-18-003243

CIK 0001427570other

View on SEC.gov Company Profile

Filed

May 1, 8:00 PM ET

Accepted

May 2, 7:23 AM ET

Size

4.8 KB

Accession

0001214659-18-003243

Insider Transaction Report

Form 4

Period: 2018-04-30

OBALON THERAPEUTICS INCOBLN

VP of Research and Development

Transactions

Award
Common Stock
2018-04-30$3.27/sh+2,622$8,574→ 166,492 total

Footnotes (1)

[F1]These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Documents

1 file

4
marketforms-41861.xmlPrimary
PRIMARY DOCUMENT

Issuer

OBALON THERAPEUTICS INC

CIK 0001427570

Entity typeother

Related Parties

1

filerCIK 0001323223

Filing Metadata

Form type: 4
Filed: May 1, 8:00 PM ET
Accepted: May 2, 7:23 AM ET
Size: 4.8 KB

View on SEC.gov